Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
September 22, 2023

FDA approves Krystal Biotech’s KB408 for AATD treatment

The US Food and Drug Administration (FDA) has granted clearance to Krystal Biotech’s investigational new drug application (IND) for KB408 to treat alpha-1 antitrypsin deficiency (AATD), a rare genetic disease.

Continue
KB408 is intended for the treatment of alpha-1 antitrypsin deficiency. Credit: Jerad M Gardner/commons.wikimedia.org.
September 21, 2023

WuXi XDC opens new GMP facilities in China

Opening of the new commercial Good Manufacturing Practices facilities. Credit: WuXi XDC.
September 19, 2023

Kymera receives FDA fast track designation for KT-333

KT-333 is intended for the treatment of Relapsed/Refractory Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma. Credit: Nephron/commons.wikimedia.org.

Contracts

December 14, 2022

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Micrograph of psoriasis vulgaris. Credit: Jenny Giang, Marc A. J. Seelen, Martijn B. A. van Doorn, Robert Rissmann,Errol P. Prens and Jeffrey Damman/ commons.wikimedia.org.

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Harbour BioMed, Moderna partner on immunotherapies development

Kite, Refuge sign license deal for gene expression platform for blood cancers

Deals

Deals August 15, 2023

Eli Lilly and Company completes acquisition of Versanis Bio

Pharmaceutical Business Review

GSK acquires pharma firm Bellus Health for $2bn

EdgeCap Partners buys majority stake in Comac Medical

Chiesi Farmaceutici acquires biopharmaceutical firm Amryt Pharma

Popular

  1. ViiV Healthcare receives European Commission approval for Apretude
  2. UK’s NICE recommends QUVIVIQ to treat chronic insomnia in adults
  3. Nona and BeiGene agree to expand antibody discovery partnership
  4. Synaffix, ABL Bio partner to develop bispecific ADCs
  5. Salipro and Sumitomo Pharma sign partnership for drug discovery programme

PRESS RELEASES

Tosoh at the BioProcess International Conference ‒ 19-21 September in Boston, MA
Tosoh at the BioProcess International Conference ‒ 19-21 September in Boston, MA
Unique Solutions, Endless Possibilities: Meet with Procaps Group During CPHI Barcelona 2023
Unique Solutions, Endless Possibilities: Meet with Procaps Group During CPHI Barcelona 2023
Insight: Helium Supply and the Increase in the Use of Hydrogen as a Gas Chromatography Carrier Gas
Insight: Helium Supply and the Increase in the Use of Hydrogen as a Gas Chromatography Carrier Gas
Gerresheimer Joins the Science Based Targets Initiative
Gerresheimer Joins the Science Based Targets Initiative
Molnar at EUROANALYSIS 2023 Conference ‒ 27-31 August 2023 in Geneva, Switzerland
Molnar at EUROANALYSIS 2023 Conference ‒ 27-31 August 2023 in Geneva, Switzerland

Suppliers

Whitepapers

The Importance of Excipient Testing
The Importance of Excipient Testing
Changing from Helium to Hydrogen
Changing from Helium to Hydrogen
Saving Through Partnership and Innovation
Saving Through Partnership and Innovation